Form D · Biotechnology

Apollo Endosurgery, Inc.

Austin, TX · CIK 0001251769

Offering snapshot reported Jul 30, 2020 · SEC filing

Reported sold
$25M
Offering amount: $25M
Investors reported
18
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 21, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 30, 2020Initial$24,982,480No comparison18SEC filing
Aug 27, 2019Initial$20,000,000No comparison18SEC filing
Oct 7, 2014Initial$12,527,521No comparison3SEC filing
Dec 1, 2010Initial$4,884,700No comparison52SEC filing
Oct 3, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Feb 8, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$1.58M
Finders' fees
$0
Form D file number
021-372158

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Craig-Hallum Capital Group LLC121395

Source: Form D, filed Jul 30, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Rick Anderson Director
Gary J G Atkinson Executive
John Barr Director
Stefanie Cavanaugh Executive
Matthew S. Crawford Director
Jeffrey A. Ferrell Director
Christopher J. Gostout Executive
Daniel L. Kisner Director
Charles A. Mathews Director
William D. Mc Clellan Director
R. Kent Mc Gaughy, Jr. Director
John Molesphini Executive
Todd Newton Director, Executive
David C. Pacitti Director
Scott R. Pancoast Director, Executive
Daniel H. Petree Director
Bruce Robertson Director
Bret Schwartzhoff Executive
Julie Shimer Director
Donald R. Swortwood Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1120 South Capital Of Tx Hwy Building 1 Suite 300
Austin, TX, 78746